3rd Circ. Denies GSK Rehearing Bid In Flonase Antitrust Suit

The Third Circuit on Wednesday said it won’t reconsider its decision to let Louisiana sue GlaxoSmithKline for allegedly blocking a generic version of its nasal spray Flonase despite the state not...

Already a subscriber? Click here to view full article